Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

biote (BTMD) Net Cash Flow: 2021-2024

Historic Net Cash Flow for biote (BTMD) over the last 4 years, with FY2024 value amounting to -$49.6 million.

  • biote's Net Cash Flow fell 2850.01% to $8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.2 million, marking a year-over-year increase of 6277.16%. This contributed to the annual value of -$49.6 million for FY2024, which is 60702.76% down from last year.
  • As of FY2024, biote's Net Cash Flow stood at -$49.6 million, which was down 60702.76% from $9.8 million recorded in FY2023.
  • In the past 5 years, biote's Net Cash Flow ranged from a high of $52.5 million in FY2022 and a low of -$49.6 million during FY2024
  • Moreover, its 4-year median value for Net Cash Flow was $9.7 million (2021), whereas its average is $5.5 million.
  • As far as peak fluctuations go, biote's Net Cash Flow soared by 44822.36% in 2022, and later plummeted by 60702.76% in 2024.
  • Annual analysis of 4 years shows biote's Net Cash Flow stood at $9.6 million in 2021, then skyrocketed by 448.22% to $52.5 million in 2022, then plummeted by 81.34% to $9.8 million in 2023, then crashed by 607.03% to -$49.6 million in 2024.
  • Its Net Cash Flow was -$49.6 million in FY2024, compared to $9.8 million in FY2023 and $52.5 million in FY2022.